BCL2 and colorectal carcinoma: Figure 5 shows the expression levels of major anti-apoptotic (i.e., BCL-2 and BCL-xL) and pro-apoptotic (i.e., TP53, BAX) genes in the CRC cell lines HT29 and SW620 after treatment with various concentrations (7.94, 15.88, and 31.76 μM) of the IMBZC compound, compared to untreated cells (i.e., control).